Accepted Manuscript Factors associated with recurrence after colpocleisis for pelvic organ prolapse in elderly women Moon Kyoung Cho, Jong Ho Moon, Chul Hong Kim PII:
S1743-9191(17)30580-0
DOI:
10.1016/j.ijsu.2017.06.086
Reference:
IJSU 3983
To appear in:
International Journal of Surgery
Received Date: 14 June 2017 Revised Date:
1743-9191 1743-9191
Accepted Date: 28 June 2017
Please cite this article as: Cho MK, Moon JH, Kim CH, Factors associated with recurrence after colpocleisis for pelvic organ prolapse in elderly women, International Journal of Surgery (2017), doi: 10.1016/j.ijsu.2017.06.086. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT 1
Factors associated with recurrence after colpocleisis for pelvic organ
3
prolapse in elderly women
4
Moon Kyoung Cho, M.D., Ph.D., Jong Ho Moon, M.D., Chul Hong Kim, M.D., Ph.D.
RI PT
2
5
Department of Obstetrics and Gynecology, Chonnam National University Medical School,
7
Gwangju, Korea
M AN U
8
SC
6
MK Cho: Manuscript writing/editing
10
JH Moon: Manuscript writing/editing
11
CH Kim: Project development, Data Collection, Manuscript editing
12
TE D
9
*Corresponding author: Chul Hong Kim, M.D., Ph.D.
14
Department of Obstetrics and Gynecology, Chonnam National University Medical School, 8
15
Hakdong, Dong-gu, Gwangju, Republic of Korea
16
E-mail:
[email protected]
17
Tel: +82-62-220-6227; Fax: +82-62-227-1637
AC C
18
EP
13
19
*Word count: Abstract 114 Manuscript 1,952
20
*Conflicts of interest: None.
21
ACCEPTED MANUSCRIPT Ethical Approval
23
The study was approved by the Institutional Review Board of Human Research of Chonnam
24
National University Hospital.
AC C
EP
TE D
M AN U
SC
RI PT
22
ACCEPTED MANUSCRIPT 1
Factors associated with recurrence after colpocleisis for pelvic organ
2
prolapse in elderly women
AC C
EP
TE D
M AN U
SC
RI PT
3
ACCEPTED MANUSCRIPT 4
Factors associated with recurrence after colpocleisis for pelvic organ
6
prolapse in elderly women
RI PT
5
7
ABSTRACT
9
Introduction: The aim of this study was to evaluate the factors associated with recurrence
SC
8
after colpocleisis for pelvic organ prolapse in elderly women.
11
Methods: This was a retrospective cohort study of patients who underwent colpocleisis for
12
stage 3 or 4 pelvic organ prolapse at a single tertiary center from January 2007 to December
13
2015.
14
Results: A total of 107 patients who underwent colpocleisis were reviewed. Duration from
15
prolapse occurrence to surgery was significantly longer (24.6 ± 22.8 years vs 8.0 ± 12.9 years,
16
p=0.021) in patients who had recurrence after colpocleisis than in those without recurrence.
17
Conclusion: Duration of prolapse was longer in patients with recurrence than in those who
18
had a successful outcome.
20 21
TE D
EP
AC C
19
M AN U
10
Keywords: Colpocleisis; Recurrence; Pelvic organ prolapse
ACCEPTED MANUSCRIPT 22
Introduction Pelvic organ prolapse (POP) is downward descent of female pelvic organs, including the
24
bladder, bowel, uterus, or post-hysterectomy vaginal cuff, resulting in protrusion of the
25
vagina, uterus, or both [1]. Despite the lack of studies assessing the prevalence of POP,
26
currently, it is known that the overall prevalence ranges from 3-50% [2]. As life expectancy
27
increases, disorders associated with aging, including POP, are becoming more prevalent.
28
Demand for care for POP is expected to increase by 35% between 2010 and 2030 [3].
SC
RI PT
23
The management of POP includes non-surgical and surgical management. For severe POP,
30
most pelvic surgeons prefer surgical treatment. The surgical management is classified as
31
restorative surgery using the patient’s endogenous supportive tissue, compensatory surgery
32
using synthetic or biological material, and obliterative surgery which closes the vagina [4].
33
However, pelvic reconstructive surgery in elderly women can be associated with significant
34
morbidity. Obliterative surgery, such as colpocleisis, is associated with less morbidity
35
compared with reconstructive surgery [5]. For elderly patients with significant medical
36
comorbidity who do not desire preservation of the vaginal anatomy for sexual function,
37
obliterative surgery may be an appropriate choice [6]. Because most of the candidates for
38
colpocleisis have a significant medical comorbidity, failure of surgery is stressful for both the
39
patient and the surgeon. The purpose of this study was to evaluate the risk factors for
40
recurrence after colpocleisis.
TE D
EP
AC C
41
M AN U
29
ACCEPTED MANUSCRIPT 42
Materials and methods In this retrospective cohort study, we reviewed the risk factors and outcomes of women with
44
primary or recurrent POP who underwent colpocleisis at this Hospital from January 2007 to
45
December 2015. Women with stage III or IV POP with a significant medical and surgical risk
46
for reconstructive pelvic surgery were included. All women did not wish to preserve coital
47
function. Women with post-menopausal bleeding, pelvic malignancy, or desire to preserve
48
sexual function were excluded from the study.
SC
RI PT
43
All of the patients underwent a complete preoperative evaluation that included history,
50
physical examination, and urinalysis. All of the patients were examined vaginally in the
51
supine position with a Sims speculum during a Valsalva maneuver, and the prolapse severity
52
was measured with the Pelvic Organ Prolapse Quantification system (POP-Q, International
53
Continence Society) [7]. Gynecologic transvaginal ultrasonography was performed to rule
54
out uterine and adnexal diseases in all of the patients. A complete multichannel urodynamic
55
study (UDS) was also performed after uterus reduction using ring forceps. The UDS included
56
free uroflowmetry, filling cystometry with a stress test, voiding cystometry, and urethral
57
pressure profilometry. The diagnosis of occult urodynamic stress incontinence was made if
58
urinary leakage occurred during the POP reduction. Prior to surgery, all of the patients
59
received vaginal estrogen therapy for at least 1 month. All patients complete the short form of
60
the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire
61
(PFIQ-7).
AC C
EP
TE D
M AN U
49
62
Colpocleisis was performed in the following manner: Traction was placed on the cervix with
63
a tenaculum. Areas to be denuded anteriorly and posteriorly were marked with a sterile
64
marking pen. The rectangular piece of the anterior vaginal wall was extended from 2 cm
65
proximal to the tip of the cervix to approximately 5 cm below the external urethral meatus.
ACCEPTED MANUSCRIPT Vaginal epithelium was infiltrated with vasopressin diluted with 0.9% saline (1:50). Sharp
67
and blunt dissection was used to remove the vaginal epithelium. Sufficient vagina was left
68
bilaterally to form canals for draining cervical secretions or blood. The cut edge of the
69
anterior vaginal wall was sewn to the cut edge of the posterior vaginal wall with interrupted
70
1.0 Vicryl sutures to gradually push the uterus and the vaginal apex inward. After the entire
71
vagina had been inverted, the superior and inferior margins over the rectangle were sutured
72
horizontally. Perineorrhaphy and distal levatorplasty were performed to increase posterior
73
pelvic muscle support and to narrow the introitus. A concomitant midurethral sling operation,
74
tension free vaginal tape–obturator (TVT-O; Gynecare, TVT-Obturator System, Ethicon, Inc.),
75
was performed in women with known or occult urodynamic stress incontinence.
M AN U
SC
RI PT
66
All of the surgeries were performed by a single surgeon. All of the patients were
77
administered first-generation cephalosporin intravenously 1 hour before surgery and they
78
underwent a prophylactic antiseptic vaginal wash with iodine-containing soap before the
79
surgery. The mode of anesthesia was dependent on the patient’s condition and preferences.
80
Postoperative follow-up was scheduled at 1 and 3 months, and 1 year, and every 6 months
81
thereafter. At each visit, all of the POP-Q points were measured by the same individual.
82
Recurrence was defined as a POP-Q stage greater than II, on the basis of the most dependent
83
point and whether it occurred at the primary site or at a new location.
85
EP
AC C
84
TE D
76
The procedure was approved by the Institutional Review Board and an informed consent was obtained.
86
Statistical analysis was performed with SPSS 20.0 for Windows (SPSS, Inc., Chicago, IL).
87
Student's t-test was used for comparison of quantitative variables between groups. Fisher’s
88
exact test was used to compare qualitative variables. A p value of less than 0.05 was
89
considered statistically significant.
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
90
ACCEPTED MANUSCRIPT 91
Results A total of 107 patients underwent colpocleisis. Mean age at operation was 75.5 ± 5.8 years
93
(range, 60-90 years), mean body mass index was 23.6 ± 3.2 kg/m2, and mean follow-up
94
duration was 7.2 ± 9.4 months (range, 1-51 months). Mean parity was 4.7 ± 1.7 (range, 1-10).
95
Among these 107 patients, 91 (85.0%) women had at least one medical comorbidity. Also, 28
96
(26.2%) women and 23 (21.5%) women had undergone previous hysterectomy and previous
97
POP surgery, respectively. Mean duration from occurrence of POP to surgery was 9.1 years
98
(range, 0-53 years). The clinical characteristics of women who underwent colpocleisis are
99
shown in Table 1. Patient symptom and physical examination are presented in Table 2.
M AN U
SC
RI PT
92
All patients underwent perineorrhaphy and distal levatorplasty, and 9 (8.4%) patients
101
underwent TVT-O for stress urinary incontinence. Mean operation time in 107 patients was
102
57.7 ± 17.5 minutes (range, 35-185 minutes). Mean hospital stay was 6.3 ± 3.6 days (range,
103
4-34 days), and mean postoperative hospital stay was 4.2 ± 2.7 days (range, 2-26 days). Mean
104
length of time from operation to recurrence was 3.3 ± 2.9 months (range, 1-9 months).
105
Postoperative 3 month and 6 month follow-up rates were 71.0% (76/107) and 43.0% (46/107),
106
respectively. Seven women were recurred after colpocleisis; three women underwent
107
colposacropexy, two underwent colpocleisis, and two patient follow-up without surgery.
AC C
EP
TE D
100
108
Comparison of operation outcome between the recurrent group and the successful group is
109
presented in Table 3. There were no difference between the recurrent and successful groups in
110
operation time, hospital stay, postoperative hospital stay, and accompanied TVT-O operation.
111
Postoperative complications were not significantly different depending on recurrence.
112
We evaluated the risk factors for recurrence after colpocleisis. In univariate analysis,
113
duration from prolapse occurrence to surgery was significantly longer (24.6 ± 22.8 years vs
ACCEPTED MANUSCRIPT 114
8.0 ± 12.9 years, p=0.021) in patients who had recurrence after colpocleisis than in those with
115
a successful outcome. Other parameters were not associated with recurrence (Table 4).
AC C
EP
TE D
M AN U
SC
RI PT
116
ACCEPTED MANUSCRIPT Discussion
118
Because of medical comorbidity and anesthetic risk, surgical management of POP in elderly
119
women with poor functional status is burdensome. For this reason, colpocleisis may be an
120
ideal surgical option in elderly patients with significant comorbidity. However, recurrence of
121
prolapse after colpocleisis is very troublesome for both the patient and the surgeon. The
122
purpose of this study was to evaluate the risk factors for recurrence after colpocleisis.
In this study, the success rate of colpocleisis was 93.5%. Results of previous reports
SC
123
RI PT
117
124
assessing the success rate were similar to those in this study [8-12].
125
comparable improvements in quality of life and postoperative patient satisfaction in women
126
who underwent either reconstructive or obliterative surgery [8]. In a study of 87 patients, it
127
was observed that colpocleisis improves body image and pelvic floor symptoms [9].
M AN U
Murphy et al. reported
Krissi et al. reported that the risk factors for recurrence after colpocleisis were greater
129
postoperative total vaginal length and wider genital hiatus [12]. In this study, patients who
130
were recurred showed greater postoperative total vaginal length and wider genital hiatus, but
131
not statistically significant.
EP
TE D
128
Parameter that was significantly associated with recurrence was duration between POP
133
occurrence and colpocleisis. Our result shows that women with recurrence had a longer (24.6
134
± 22.8 years vs 8.0 ± 12.9 years) duration between POP occurrence and surgery than women
135
with a successful outcome. In a study of 47 patients, there was no significant difference in
136
prolapse duration [12]. In this study, 107 women showed a longer (9.1 ± 14.2 years vs 61.9 ±
137
50.1 months) mean duration of prolapse than that in the report by Krissi et al. This large
138
difference may have originated from the unique Korean culture. The expression and
139
discussion of sexuality is usually very conservative in Korea, as in other Asian countries [13].
AC C
132
ACCEPTED MANUSCRIPT Adults in Korea regard sexuality as an important part of life, but only 2% of men and women
141
have discussed sexual dysfunction with a medical doctor [14]. Due to conservative cultural
142
characteristics, unfortunately many patients, especially elderly patients, feel embarrassed to
143
visit an urogynecologist for POP and are not willing to seek medical treatment.
RI PT
140
Reasons for the association of duration of prolapse with increasing rate of recurrence after
145
colpocleisis are unclear. On the other hand, there are few reports that evaluated the role of
146
preoperative vaginal estrogen application in women with POP who underwent surgical
147
management [15]. Rahn et al. reported that preoperative local estrogen application increased
148
synthesis of mature collagen, decreased degradative enzyme activity, and increased thickness
149
of the vaginal wall, suggesting that this intervention improves both the substrate for suture
150
placement and maintenance of connective tissue integrity [16]. Thus, our finding may suggest
151
that patients with prolonged duration of prolapse need proper preoperative vaginal estrogen
152
application to improve the substrate for suture placement.
TE D
M AN U
SC
144
Candidates for colpocleisis usually have poor health status with significant comorbidity, and
154
many patients need preoperative management, e.g. blood pressure monitoring in patients with
155
hypertension, blood glucose monitoring in women with diabetes mellitus. For this reason, we
156
analyzed not only the mean hospital stay but also the postoperative hospital stay. Mean
157
hospital stay was 6.3 ± 3.6 days (range, 4-34 days) and mean postoperative hospital stay was
158
4.2 ± 2.7 days (range, 2-26 days) in all 107 patients.
AC C
EP
153
159
There were no serious postoperative complications. There were few minor postoperative
160
complications, e.g. urinary tract infection, fecal incontinence, and vulvar edema. The total
161
complication rate was 16.8% (18/107) in this study. Two patients received packed red blood
162
cell transfusion. Zebede et al. reported that the total complication rate of colpocleisis was
163
15.2% (47/310), and there was a need to perform an additional procedure during colpocleisis
ACCEPTED MANUSCRIPT 164
[11]. Catanzarite et al. reported that the complication rate was 8.1 % (23/283) during 30 days
165
after colpocleisis [17]. The limitations of this study are its retrospective study design, a relatively small sample size,
167
and lack of information on the quality of life. Another limitation is that the date of POP
168
occurrence was obtained based on the patient’s memory which is not accurate especially in
169
elderly patients and there was a long prolapse duration. The strength of this study is that all
170
surgeries and follow-ups were performed by the same individual. Because of the Asian
171
cultural characteristics, we unintentionally evaluated the association between prolapse
172
duration and recurrence.
M AN U
SC
RI PT
166
AC C
EP
TE D
173
ACCEPTED MANUSCRIPT Conclusion
175
Duration from POP occurrence to surgery were the only parameters that were significantly
176
associated with recurrence after colpocleisis. Therefore, women with a very long duration of
177
prolapse should be counseled about possible recurrence of disease.
RI PT
174
AC C
EP
TE D
M AN U
SC
178
ACCEPTED MANUSCRIPT 179
180
Funding: none Conflict of interest: None
AC C
EP
TE D
M AN U
SC
RI PT
181
ACCEPTED MANUSCRIPT 182
References
183
[1] Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet 2007;369:1027-1038.
184
[2] Barber, M.D. & Maher, C. Epidemiology and outcome assessment of pelvic organ
188 189
190 191
192 193
RI PT
of pelvic floor disorders in the United States. Am J Obstet Gynecol 2013;209:584.e1-5
SC
187
[3] Kirby AC, Luber KM, Menefee SA. An update on the current and future demand for care
[4] Choi KH, Hong JY. Management of Pelvic Organ Prolapse. Korean J Urol. 2014 Nov;55(11):693-702.
M AN U
186
prolapse. Int Urogynecol J 2013;24:1783.
[5] Erekson EA, Yip SO, Ciarleglio MM, Fried TR. Postoperative complications after gynaecologic surgery. Obstet Gynecol 2011;118(4):785–793.
[6] Fitzgerald MP, Richter HE, Siddique S, et al. Colpocleisis: a review. Int Urogynecol J. 2006;17(30):261–271.
TE D
185
[7] Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The
195
standardization of terminology of female pelvic organ prolapse and pelvic floor
196
dysfunction. Am J Obstet Gynecol. 1996;175:10–17.
AC C
EP
194
197
[8] Murphy M, Sternschuss G, Haff R, van Raalte H, Saltz S, Lucente V. Quality of life and
198
surgical satisfaction after vaginal reconstructive vs obliterative surgery for the treatment of
199
advanced pelvic organ prolapse. Am J Obstet Gynecol. 2008;198(5):573.
200
[9] Crisp CC, Book NM, Smith AL, Cunkelman JA, Mishan V, Treszezamsky AD, Adams SR,
201
Apostolis C, Lowenstein L, Pauls RN; Fellows' Pelvic Research Network, Society of
202
Gynecologic Surgeons. Body image, regret, and satisfaction following colpocleisis. Am J
203
Obstet Gynecol. 2013;209(5):473.
ACCEPTED MANUSCRIPT [10] Fitzgerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, Zyczynski HM,
205
Fine P, Weber AM; Pelvic Floor Disorders Network. Pelvic support, pelvic symptoms, and
206
patient satisfaction after colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct.
207
2008;19(12):1603-9.
RI PT
204
[11] Zebede S, Smith AL, Plowright LN, Hegde A, Aguilar VC, Davila GW. Obliterative
209
LeFort colpocleisis in a large group of elderly women. Obstet Gynecol. 2013;121(2 Pt
210
1):279-84.
SC
208
[12] Krissi H, Aviram A, Eitan R, From A, Wiznitzer A, Peled Y Risk factors for recurrence
212
after Le Fort colpocleisis for severe pelvic organ prolapse in elderly women. Int J Surg.
213
2015;20:75-9.
M AN U
211
[13] Lee ZN. Korean culture and sense of shame. Transcult Psychiatry 1999; 36: 181-94.
215
[14] Moreira ED Jr, Kim SC, Glasser D, Gingell C. Sexual activity, prevalence of sexual
216
problems, and associated help-seeking patterns in men and women aged 40-80 years in
217
Korea: data from the Global Study of Sexual Attitudes and Behaviors (GSSAB). J Sex
218
Med 2006; 3: 201-11.
220
EP
[15] Rachaneni S, Latthe P. Role of perioperative low dose vaginal oestrogens in improving
AC C
219
TE D
214
the outcomes of pelvic organ prolapse surgery. Med Hypotheses. 2013;81(6):1015-6.
221
[16] Rahn DD, Good MM, Roshanravan SM, Shi H, Schaffer JI, Singh RJ, Word RA. Effects
222
of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.
223
J Clin Endocrinol Metab. 2014;99(10):3728-36.
224
[17] Catanzarite T, Rambachan A, Mueller MG, Pilecki MA, Kim JY, Kenton K. Risk factors
225
for 30-day perioperative complications after Le Fort colpocleisis. J Urol. 2014;192(3):788-
ACCEPTED MANUSCRIPT
EP
TE D
M AN U
SC
RI PT
92.
AC C
226
ACCEPTED MANUSCRIPT 1
Table 1. Characteristics of 107 women who underwent colpocleisis Parameter
No (%)
Mean ± SD
Range
75.5 ± 5.8
60-90
Body mass index (kg/m2)
23.6 ± 3.2
16-37
4.6 ± 1.7
1-10
49.3 ± 4.6
37-65
26.2 ± 7.4
8-45
RI PT
Age at operation (years)
Number of vaginal deliveries Age at menopause (years)
SC
Duration of menopause (years) Duration of prolapse sensation (years)
Hypertension
1-51
34 (31.8)
IHD
13 (12.1) 12 (11.2)
Respiratory illness*
EP
Parkinson’s disease
TE D
History of CVA
CKD
7.2 ± 9.4
69 (64.5)
Diabetes mellitus
Cancer
0-53
M AN U
Comorbidity
9.1 ± 14.2
AC C
Past heart operation
7 (6.5) 7 (6.5) 8 (7.5) 2 (1.9) 2 (1.9)
Past hysterectomy
28 (26.2)
Past POP operation
23 (21.5)
Duration of follow-up (months)
IHD=ischemic heart disease, CVA=cerebrovascular accident, CKD=chronic kidney disease, POP=pelvic organ prolapse *
2
Asthma, chronic bronchitis or chronic obstructive pulmonary disease.
ACCEPTED MANUSCRIPT 3
Table 2. Physical examination and urinary symptom who underwent colpocleisis. Recurrence
Successful
(n=7)
(n=100)
P value
Preoperative physical examination, mean ± SD 4.9 ± 1.4
PB (cm)
2.6 ± 1.0
TVL (cm)
6.7 ± 1.2
Postoperative physical examination, mean ± SD
0.359
6.8 ± 0.6
0.678
0.092
3.0 ± 0.6
3.2 ± 0.8
0.275
5.2 ± 1.0
4.8 ± 0.7
0.083
4 (57.1)
54 (54.0)
0.472
4 (57.1)
71 (71.0)
0.722
Urge urinary incontinence
1 (14.3)
17 (17.0)
0.853
Stress urinary incontinence
0 (0.0)
6 (6.0)
0.505
Incomplete bladder emptying
5 (71.4)
65 (65.0)
0.667
Urge urinary incontinence
1 (14.3)
17 (17.0)
0.853
TVL (cm) Urinary symptoms, n (%)
AC C
EP
Frequency
TE D
Urgency
GH=genital hiatus, PB=perineal body, TVL=total vaginal length
5
2.9 ± 0.8
3.1 ± 0.7
PB (cm)
4
0.406
4.3 ± 1.2
M AN U
GH (cm)
4.6 ± 0.9
SC
GH (cm)
RI PT
Parameter
ACCEPTED MANUSCRIPT 6
Table 3. Comparison of operation outcome between the recurrent group and the non-recurrent
7
group. Recurrence
Successful
(n=7)
(n=100)
63.6 ± 21.4
53.4 ± 17.3
0.347
Hospital stay (days)
5.3 ± 1.6
6.4 ± 3.7
0.325
Postoperative hospital stay (days)
3.6 ± 1.1
4.2 ± 2.7
0.370
P value
SC
Operation time (minutes)
Accompanied TOT
0 (0.0)
9 (9.0)
0.531
0 (0.0)
6 (6.0)
0.660
0 (0.0)
5 (5.0)
0.708
0 (0.0)
2 (2.0)
0.873
0 (0.0)
2 (2.0)
0.873
0 (0.0)
3 (3.0)
0.815
M AN U
Complication UTI Postoperative bleeding Fecal incontinence
TE D
Vulvar edema Blood transfusion
AC C
EP
TOT=trans-obturator tape, UTI=urinary tract infection 8
RI PT
Parameter
ACCEPTED MANUSCRIPT Table 4. Univariate analysis of risk factors for recurrence. Recurrence
Successful
(n=7)
(n=100)
Age at operation (years)
73.9 ± 2.1
75.6 ± 6.0
0.318
Body mass index (kg/m2)
24.0 ±3.0
23.5 ± 3.2
0.641
No. of vaginal deliveries
4.0 ± 1.5
4.7 ± 1.8
0.257
Age at menopause (years)
50.7 ± 4.6
49.3 ± 4.6
0.299
Duration of menopause (years)
23.1 ± 5.7
26.4 ± 7.5
0.136
Duration of prolapse (years)
24.6 ± 22.8
8.0 ± 12.9
0.021
64 (64.0)
5 (71.4)
0.519
32 (32.0)
2 (28.6)
0.608
13 (13.0)
0 (0.0)
0.594
11 (11.0)
1 (14.3)
0.576
7 (7.0)
0 (0.0)
0.614
6 (6.0)
1 (14.3)
0.386
8 (8.0)
0 (0.0)
0.571
2 (2.0)
0 (0.0)
0.873
2 (2.0)
0 (0.0)
0.873
Past hysterectomy
26 (26.0)
2 (28.6)
0.590
Past POP operation
21 (21.0)
2 (28.6)
0.468
Duration of follow-up (months)
11.7 ± 7.9
6.8 ± 9.4
0.022
P value
Hypertension Diabetes mellitus
History of CVA Respiratory illness*
Cancer CKD
EP
Parkinson’s disease
SC
TE D
IHD
M AN U
Comorbidity
Past heart operation
RI PT
Parameter
AC C
9
IHD=ischemic heart disease, CVA=cerebrovascular accident, CKD=chronic kidney disease, POP=pelvic organ prolapse
ACCEPTED MANUSCRIPT * Asthma, chronic bronchitis or chronic obstructive pulmonary disease.
AC C
EP
TE D
M AN U
SC
RI PT
10
ACCEPTED MANUSCRIPT 1
Factors associated with recurrence after colpocleisis for pelvic organ
3
prolapse in elderly women
RI PT
2
4
Highlights
SC
5
This study evaluated the risk factors associated with recurrence after colpocleisis.
7
For elderly patients with significant medical comorbidity who do not desire
8
preservation of the vaginal anatomy for sexual function, colpocleisis may be an
9
appropriate choice
M AN U
6
Duration from pelvic organ prolapse occurrence to surgery were the only parameters
11
that were significantly associated with recurrence after colpocleisis.
12
Women with a very long duration of prolapse should be counseled about possible
13
recurrence of disease.
AC C
EP
TE D
10